Corpus Intelligence IC Memo — BALL MEMORIAL HOSPITAL 2026-04-26 14:10 UTC
IC Memo — BALL MEMORIAL HOSPITAL
Investment Committee Memorandum | IN | 316 beds | Grade B | EBITDA uplift $38.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BALL MEMORIAL HOSPITAL

CCN 150089 | DELAWARE, IN | 316 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

BALL MEMORIAL HOSPITAL is a 316-bed suburban community hospital in DELAWARE, IN with $524.9M in net patient revenue and a 0.9% operating margin. The hospital serves a payer mix of 30.3% Medicare, 5.1% Medicaid, and 64.6% commercial.

Thesis: Undervalued. Our ML models identify $38.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 0.9% to 8.2% (+736bps).

Net Revenue HCRIS$524.9M
Current EBITDA COMPUTED$4.5M
Operating Margin COMPUTED0.9%
Occupancy HCRIS71.7%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS21.7%
Distress Probability ML42.6%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
27
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 0.9% places it above the state median. Among 27 size-comparable peers (158-632 beds), the median margin is 3.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (158-632), prioritizing same-state peers. 27 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BALL MEMORIAL HOSPITAL (Target)IN316$524.9M0.9%
COMMUNITY HEALTH NETWORK INC.IN387$1.24B16.4%
DEACONESS HOSPITALIN545$1.14B0.7%
FRANCISCAN HEALTH INDIANAPOLISIN401$891.4M-0.3%
ASCENSION ST. VINCENT EVANSVILIN346$671.8M11.4%
MEMORIAL HOSPITAL OF SOUTH BENIN429$631.5M9.7%
COMMUNITY HOSPITALIN405$615.1M6.0%
UNION HOSPITAL INC.IN258$581.9M3.8%
LUTHERAN HOSPITAL OF INDIANAIN335$580.1M3.8%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $38.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$11.0M+210bp18mo
Cost to Collect4.5%2.5%$10.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$10.4M+198bp12mo
A/R Days Reduction5200.0%3800.0%$6.4M+122bp9mo
Clean Claim Rate88.0%96.0%$336K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$11.0M
Cost to Collect
$10.5M
Denial Rate Reduction
$10.4M
A/R Days Reduction
$6.4M
Clean Claim Rate
$336K
Total EBITDA Uplift$38.6M
Current EBITDA$4.5M
+ RCM Uplift+$38.6M
Pro Forma EBITDA$43.1M
Current Margin0.9%
Pro Forma Margin8.2%
WC Released (1x)$20.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$6.9M$415.9M60.38x127.1%
Base (11x exit)10.0x11.0x$6.9M$459.7M66.74x131.7%
Bull Case9.0x11.0x$6.2M$589.5M95.08x148.7%
Bull (12x exit)9.0x12.0x$6.2M$644.9M104.02x153.2%
Bear Case11.0x10.0x$7.6M$220.5M29.10x96.2%
Bear (11x exit)11.0x11.0x$7.6M$245.0M32.33x100.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 27 hospitals with 158-632 beds
  • Same-state prioritization (n=28)
  • Comp margins: P25=-4.0% / P50=3.8% / P75=10.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.